Chemicals and Basic Materials | China M&A Consulting

Our client, a leading North American pharmaceuticals company, wanted to increase sales in China and obtain low cost production capacity to supply other markets. In a 10 week time frame we first developed acquisition criteria, identified and screened potential targets, for short listed targets we interviewed management, conduct preliminary due diligence and evaluated their interest in a strategic partnership.

Go to case Go to Acquisition Target Search

Identifying emerging trends and determining how they will change competitive dynamics is key to successful commercial due diligence. In this case, a leading China-focused private equity firm needed help evaluating an investment into a Chinese company that claimed its homegrown, IPR-protected, technology could revolutionize an entire industry.

Go to case Go to Mergers & Acquisitions

Contact Form

SSCO Shanghai Head Office

Contact

Posts

(English)

Commercial Due Diligence

Feasibility of Pharmaceutical Packaging Foil Strategy?

(English)

JVs and Strategic Partnerships

Strategic rationale for Healthcare Joint Venture

(English)

Investment Research

Long-term trends in China’s biotech industry

Entering China’s pharmaceutical market through M&A

Acquisition Target Search

Know your options, monitor your targets

A leading Chinese organic food brand in the making?

(English)

Competitive Intelligence

Emerging Chinese Competitors

Commercial Due Diligence

A rising star?

Commercial Due Diligence

A Chinese entrepreneur with world-class, IPR-protected technology?

(English)

Asia Market Research

Asia Market Assessment

China strategy and M&A advisory